SCHEMBL685153

SCHEMBL685153

CC(C)[C@H](C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2017195 1.00 ALDH1A1 (0.56)
SCHEMBL23875 1.00
SCHEMBL418078 1.00
Hydrochloric Acid SCHEMBL6645496 0.94
SCHEMBL28881845 0.94
SCHEMBL31518532 0.94
SCHEMBL27646234 0.94
Ammonia Solution, Strong SCHEMBL2679632 0.94
Methyl Alcohol SCHEMBL17241953 0.94
Ammonia Solution, Strong SCHEMBL1333597 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11424006-B2 Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide PSOMAGEN, INC. (US) 2022-08-23 US claimed
US-20210128498-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE MACROGEN INC. (KR) 2021-05-06 US claimed
EP-3668494-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE Psomagen, Inc. (US) 2020-06-24 EP claimed
CN-111163761-A Targeted drugs related to trimethylamine and/or trimethylamine-N-oxide 普梭梅根公司 2020-05-15 CN claimed
WO-2019036507-A1 TARGETED DRUGS ASSOCIATED WITH TRIMETHYLAMINE AND/OR TRIMETHYLAMINE-N-OXIDE uBiome, Inc. (US) 2019-02-21 WO claimed
US-20190050525-A1 RIESKE-TYPE OXYGENASE/REDUCTASE TARGETED DRUGS FOR DIAGNOSTIC AND TREATMENT OF DISEASES PSOMAGEN, INC. 2019-02-14 US claimed
CN-101045936-B Process of preparing chiral fatty alcohol with acid anhydride as acry radical donor UNIV JILIN 2010-06-23 CN claimed
CN-101045936-A Process of preparing chiral fatty alcohol with acid anhydride as acry radical donor UNIV JILIN (CN) 2007-10-03 CN claimed
US-20050154216-A1 Novel enantiomeric compounds for treatment of cardiac arrhythmias and methods of use ARYX THERAPEUTICS 2005-07-14 US claimed
EP-1040105-A2 METHODS FOR THE ESTERIFICATION OF ALCOHOLS AND COMPOUNDS USEFUL THEREFOR AS POTENTIAL ANTICANCER AGENTS EMORY UNIVERSITY (US) 2000-10-04 EP claimed
WO-1999031079-A2 METHODS FOR THE ESTERIFICATION OF ALCOHOLS AND COMPOUNDS USEFUL THEREFOR AS POTENTIAL ANTICANCER AGENTS EMORY UNIVERSITY (US) 1999-06-24 WO claimed
CN-119776301-A Alcohol dehydrogenase, recombinant genetically engineered bacterium and application thereof in asymmetric reduction of potential chiral carbonyl compounds 杭州文德阶生物科技有限公司 2025-04-08 CN disclosed
US-20240374598-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2024-11-14 US disclosed
US-20240218021-A1 CYCLIN INHIBITORS CIRCLE PHARMA, INC. 2024-07-04 US disclosed
US-20240025898-A1 HPK1 ANTAGONISTS AND USES THEREOF SCHRÖDINGER, INC. 2024-01-25 US disclosed
WO-1987004438-A1 NOVEL OPTICALLY ACTIVE ALKALI METAL MONO- AND DIORGANYLBOROHYDRIDES AND BORANES AND PROCESS FOR PREPARING AND USING SAME ALDRICH-BORANES, INC. (US) 1987-07-30 WO disclosed
US-4658043-A Ethers of pantolactone ROUSSEL UCLAF (FR) 1987-04-14 US disclosed
US-4540797-A Process for resolution of chiral alcohols or phenols or chiral lactonic compounds ROUSSEL UCLAF (FR) 1985-09-10 US disclosed
US-4374257-A Novel ethers containing a lactone group and a chiral atom ROUSSEL UCLAF (FR) 1983-02-15 US disclosed
US-4265817-A Novel chiral ethers and their use in resolution of alcohols and phenols ROUSSEL UCLAF (FR) 1981-05-05 US disclosed